Search
Cartesian Therapeutics Inc
RNACAdd to Watchlist
7.779USD
-0.141-1.77%
Market hours （ET）Quotes delayed by 15 min
222.06MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Springer Timothy A
29.41%
Seven One Eight Three Four Irrevocable Trust
15.50%
Squarepoint Capital LLP
7.52%
Fidelity Management & Research Company LLC
4.65%
Singer (Michael S.)
2.33%
Other
40.58%
Shareholders
Shareholders
Proportion
Springer Timothy A
29.41%
Seven One Eight Three Four Irrevocable Trust
15.50%
Squarepoint Capital LLP
7.52%
Fidelity Management & Research Company LLC
4.65%
Singer (Michael S.)
2.33%
Other
40.58%
Shareholder Types
Shareholders
Proportion
Individual Investor
36.03%
Corporation
17.74%
Investment Advisor
11.14%
Investment Advisor/Hedge Fund
10.75%
Hedge Fund
2.72%
Research Firm
0.52%
Bank and Trust
0.15%
Pension Fund
0.07%
Venture Capital
0.03%
Other
20.86%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
191
7.99M
27.21%
+636.40K
2025Q4
185
6.46M
24.83%
-1.21M
2025Q3
181
6.69M
25.71%
-763.38K
2025Q2
206
22.27M
85.81%
-1.28M
2025Q1
226
22.94M
90.08%
+138.68K
2024Q4
230
22.26M
88.90%
-105.22K
2024Q3
229
20.22M
92.77%
+6.58M
2024Q2
235
14.41M
85.20%
+9.02M
2024Q1
233
3.74M
346.71%
-1.42M
2023Q4
240
3.82M
71.00%
-922.87K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Springer Timothy A
8.64M
32.59%
+2.60K
+0.03%
Jan 02, 2026
Seven One Eight Three Four Irrevocable Trust
4.56M
17.18%
--
--
Apr 14, 2025
Squarepoint Capital LLP
2.21M
8.34%
+2.19M
+12032.00%
Mar 09, 2026
Fidelity Management & Research Company LLC
1.37M
5.16%
-788.79K
-36.59%
Dec 31, 2025
Singer (Michael S.)
683.10K
2.58%
-6.55K
-0.95%
Mar 13, 2026
TAS Partners, L.L.C.
656.51K
2.48%
+126.72K
+23.92%
Apr 14, 2025
BlackRock Institutional Trust Company, N.A.
554.24K
2.09%
-23.12K
-4.00%
Dec 31, 2025
Kalayoglu (Murat)
505.02K
1.91%
+2.60K
+0.52%
Jan 02, 2026
Lu (Chafen)
330.69K
1.25%
--
--
Apr 14, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.54%
Invesco Nasdaq Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Micro-Cap ETF
0.02%
iShares Biotechnology ETF
0.01%
ALPS Medical Breakthroughs ETF
0%
Global X Russell 2000 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.54%
Invesco Nasdaq Biotechnology ETF
Proportion0.02%
ProShares Ultra Nasdaq Biotechnology
Proportion0.02%
iShares Micro-Cap ETF
Proportion0.02%
iShares Biotechnology ETF
Proportion0.01%
ALPS Medical Breakthroughs ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%